Atlas Trials

Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD)

Clinical trial NCT00211419 · COMPLETED

Trial details

NCT number
NCT00211419
Sponsor
Manhattan Eye, Ear & Throat Hospital
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Maculopathy, Age-Related

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.